Clinical, laboratory, and neuroimaging characteristics of fatigue in HIV-infected individuals

Journal of NeuroVirology

Volumn 17, Issue 1, 2011, Pages 17-25

  Schifitto, Giovanni ^a   Deng, Lijuan ^b   Yeh, Tzu Min ^b   Evans, Scott R ^b   Ernst, Thomas ^c   Zhong, Jianhui ^a   Clifford, David ^d  

^a UNIVERSITY OF ROCHESTER   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF HAWAII   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fatigue; HIV; MRS

Indexed keywords

CREATINE; PLACEBO; SELEGILINE; VIRUS RNA;

ADULT; ARTICLE; BASAL GANGLION; CD4 LYMPHOCYTE COUNT; CLINICAL EVALUATION; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE DEFECT; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; EDUCATIONAL STATUS; ENERGY METABOLISM; FATIGUE; FATIGUE SEVERITY SCALE; FEMALE; FOLLOW UP; FRONTAL LOBE; FUNCTIONAL STATUS; GENDER; GRAY MATTER; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; RACE DIFFERENCE; RATING SCALE; SCORING SYSTEM; WHITE MATTER;

ADULT; BIOLOGICAL MARKERS; BRAIN; CD4 LYMPHOCYTE COUNT; CREATINE; DOUBLE-BLIND METHOD; FATIGUE; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RNA, VIRAL;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 79952965442     PISSN: 13550284     EISSN: 15382443     Source Type: Journal    
DOI: 10.1007/s13365-010-0010-5     Document Type: Article

References (48)

1. Breitbart W, McDonald MV, Rosenfeld B, Monkman ND, Passik S (1998) Fatigue in ambulatory AIDS patients. J Pain Symptom Manage 15:159-167 (Pubitemid 28169138)
2. Brinkman K, Smeitink JA, Romijn JA, Reiss P (1999) Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviraltherapy-related lipodystrophy. Lancet 354:1112-1115 (Pubitemid 29452832)
3. Capuron L, Pagnoni G, Demetrashvili MF et al (2007) Basal ganglia hypermetabolism and symptoms of fatigue during interferonalpha therapy. Neuropsychopharmacology 32:2384-2392 (Pubitemid 47587675)
4. Carr A, Cooper DA (2000) Adverse effects of antiretroviral therapy. Lancet 356:1423-1430
5. Carr A, Miller J, Law M, Cooper DA (2000) A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome. AIDS 14:F25-F32 (Pubitemid 30132938)
6. Chang L, Ernst T, Witt MD, Ames N, Gaiefsky M, Miller E (2002) Relationships among brain metabolites, cognitive function, and viral loads in antiretroviral-naive HIV patients. Neuroimage 17:1638-1648 (Pubitemid 35333882)
7. Chaudhuri A, Behan PO (2000) Fatigue and basal ganglia. J Neurol Sci 179:34-42
8. Cleary PD, Fowler FJ, Weissman J et al (1993) Health-related quality of life in persons with Acquired Immune Deficiency Syndrome. Med Care 31:569-580
9. Clifford DB, McArthur JC, Schifitto G et al (2002) A randomized clinical trial of CPI-1189 for HIV-associated cognitive-motor impairment. Neurology 59:1568-1573 (Pubitemid 35387064)
10. Collado-Hidalgo A, Bower JE, Ganz PA, Cole SW, Irwin MR (2006) Inflammatory biomarkers for persistent fatigue in breast cancer survivors. Clin Cancer Res 12:2759-2766
11. Cote HCF, Brumme ZL, Craib KJP et al (2002) Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients. N Engl J Med 346:811-820 (Pubitemid 34984654)
12. Dalakas MC, Semino-Mora C, Leon-Monzon M (2001) Mitochondrial alterations with mitochondrial DNA depletion in the nerves of AIDS patients with peripheral neuropathy induced by 2'3'-dideoxycytidine (ddC). Lab Invest 81:1537-1544 (Pubitemid 33064279)
13. Darko DF, McCutchan JA, Kripke DF, Gillin JC, Golshan S (1992) Fatigue, sleep disturbance, disability, and indices of progression of HIV infection. Am J Psychiatry 149:514-520
14. Delgado J, Harris M, Tesiorowski A, Montaner JS (2001) Symptomatic elevations of lactic acid and their response to treatment manipulation in human immunodeficiency virus-infected persons: a case series. Clin Infect Dis 33:2072-2074 (Pubitemid 33152404)
15. Deluca J, Genova HM, Hillary FG, Wylie G (2008) Neural correlates of cognitive fatigue in multiple sclerosis using functional MRI. J Neurol Sci 270(1-2):28-39
16. Duran S, Spire B, Raffi F et al (2001) Self-reported symptoms after initiation of a protease inhibitor in HIV-infected patients and their impact on adherence to HAART. HIV Clin Trials 2:38-45 (Pubitemid 32181748)
17. Ferrando S, Evans S, Goggin K, Sewell M, Fishman B, Rabkin J (1998) Fatigue in HIV illness: relationship to depression, physical limitations, and disability. Psychosom Med 60:759-764 (Pubitemid 28544040)
18. Heesen C, Nawrath L, Reich C, Bauer N, Schulz KH, Gold SM (2006) Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour? J Neurol Neurosurg Psychiatry 77:34-39 (Pubitemid 43022687)
19. Herlofson K, Larsen JP (2003) The influence of fatigue on healthrelated quality of life in patients with Parkinson's disease. Acta Neurol Scand 107:1-6 (Pubitemid 36177324)
20. Jones G, Power C (2006) Regulation of neural cell survival by HIV-1 infection. Neurobiol Dis 21:1-17 (Pubitemid 41817300)
21. Justice AC, Rabeneck L, Hays RD, Wu AW, Bozzette SA (1999) Sensitivity, specificity, reliability, and clinical validity of provider-reported symptoms: a comparison with self-reported symptoms. Outcomes Committee of the AIDS Clinical Trials Group. J Acquir Immune Defic Syndr 21:126-133
22. Kakuda TN, Brundage RC, Anderson PL, Fletcher CV (1999) Nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity as an etiology for lipodystrophy. AIDS 13:2311-2312 (Pubitemid 29531456)
23. Kim MJ, Leclercq P, Lanoy E et al (2007) A 6-month interruption of antiretroviral therapy improves adipose tissue function in HIV-infected patients: the ANRS EP29 Lipostop Study. Antivir Ther 12:1273-1283
24. Kleinman L, Zodet MW, Hakim Z et al (2000) Psychometric evaluation of the fatigue severity scale for use in chronic hepatitis C. Qual Life Res 9:499-508 (Pubitemid 32009860)
25. Kos D, Kerckhofs E, Nagels G, D'hooghe MB, Ilsbroukx S (2008) Origin of fatigue in multiple sclerosis: review of the literature. Neurorehabil Neural Repair 22:91-100 (Pubitemid 350223141)
26. Kreis R, Ernst T, Ross BD (1993) Absolute quantitation of water and metabolites in the human brain. II. Metabolite concentrations. J Magn Reson B 102:9-19
27. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD (1989) The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46:1121-1123 (Pubitemid 19246303)
28. Lyketsos CG, Hoover DR, Guccione M et al (1996) Changes in depressive symptoms as AIDS develops. The Multicenter AIDS Cohort Study. Am J Psychiatry 153:1430-1437 (Pubitemid 26365457)
29. McArthur JC, McDermott MP, McClernon D et al (2004) Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapy.[Erratum appears in Arch Neurol. 2005 Jul;62(7):1110]. Arch Neurol 61:1687-1696 (Pubitemid 39463427)
30. McElhiney M, Rabkin J, Van Gorp W, Rabkin R (2009) Modafinil effects on cognitive function in HIVpatients treated for fatigue: a placebo controlled study. J Clin Exp Neuropsychol 32(5):474-480
31. Millikin CP, Rourke SB, Halman MH, Power C (2003) Fatigue in HIV/AIDS is associated with depression and subjective neurocognitive complaints but not neuropsychological functioning. J Clin Exp Neuropsychol 25:201-215 (Pubitemid 36459568)
32. Molassiotis A, Nahas-Lopez V, Chung WY, Lam SW, Li CK, Lau TF (2002) Factors associated with adherence to antiretroviral medication in HIV-infected patients. Int J STD AIDS 13:301-310 (Pubitemid 34492965)
33. avia BA, Cho E-S, Petito CK, Price RW (1986) The AIDS dementia complex: II. Neuropathology. Ann Neurol 19:525-535
34. Perkins DO, Leserman J, Stern RA et al (1995) Somatic symptoms and HIV infection: relationship to depressive symptoms and indicators of HIV disease. Am J Psychiatry 152:1776-1781
35. Phillips KD, Sowell RL, Rojas M, Tavakoli A, Fulk LJ, Hand GA (2004) Physiological and psychological correlates of fatigue in HIV disease. Biol Res Nurs 6:59-74 (Pubitemid 44005155)
36. Rabkin JG, McElhiney MC, Rabkin R, Ferrando SJ (2004) Modafinil treatment for fatigue in HIV+ patients: a pilot study. J Clin Psychiatry 65:1688-1695
37. Rabkin JG, McElhiney MC, Rabkin R, McGrath PJ (2010) Modafinil treatment for fatigue in HIV/AIDS: a randomized placebocontrolled study. J Clin Psychiatry 71(6):707-15
38. Roelcke U, Kappos L, Lechner-Scott J et al (1997) Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a 18 F-fluorodeoxyglucose positron emission tomography study. Neurology 48:1566-1571
39. Schifitto GM, McDermott MPP, McArthur JCM et al (2005) Markers of immune activation and viral load in HIV-associated sensory neuropathy. Neurology 64:842-848
40. Schifitto G, Zhang J, Evans SR et al (2007) A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment. Neurology 69:1314-1321 (Pubitemid 47482445)
41. Schifitto G, Friedman JH, Oakes D et al (2008) Fatigue in levodopa-naive subjects with Parkinson disease. Neurology 71:481-485
42. Schifitto G, Yiannoutsos CT, Ernst T et al (2009) Selegiline and oxidative stress in HIV-associated cognitive impairment. Neurology 73:1975-1981
43. Shulman LM, Taback RL, Bean J, Weiner WJ (2001) Comorbidity of the nonmotor symptoms of Parkinson's disease. Mov Disord 16:507-510 (Pubitemid 36041156)
44. Silverberg MJ, Gore ME, French AL et al (2004) Prevalence of clinical symptoms associated with highly active antiretroviral therapy in the Women's Interagency HIV Study. Clin Infect Dis 39:717-724 (Pubitemid 39180446)
45. Sullivan PS, Dworkin MS (2003) Prevalence and correlates offatigue among persons with HIV infection. J Pain Symptom Manage 25:329-333 (Pubitemid 36411788)
46. Voss JG (2005) Predictors and correlates of fatigue in HIV/AIDS. J Pain Symptom Manage 29:173-184 (Pubitemid 40279054)
47. Wilson IB, Cleary PD (1996) Clinical predictors of functioning in persons with Acquired Immunodeficiency Syndrome. Med Care 34:610-623 (Pubitemid 126433260)
48. Witjas T, Kaphan E, Azulay JP et al (2002) Nonmotor fluctuations in Parkinson's disease: frequent and disabling. Neurology 59:408-413 (Pubitemid 34857934)